| UniProt ID | CKLF6_HUMAN | |
|---|---|---|
| UniProt AC | Q9NX76 | |
| Protein Name | CKLF-like MARVEL transmembrane domain-containing protein 6 {ECO:0000303|PubMed:28813417} | |
| Gene Name | CMTM6 {ECO:0000303|PubMed:28813417, ECO:0000312|HGNC:HGNC:19177} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 183 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . Early endosome membrane Multi-pass membrane protein . Recycling endosome membrane Multi-pass membrane protein . Co-localizes with PD-L1/CD274 in the plasma membrane and in recycling endosomes. |
|
| Protein Description | Master regulator of recycling and plasma membrane expression of PD-L1/CD274, an immune inhibitory ligand critical for immune tolerance to self and antitumor immunity. Associates with both constitutive and IFNG-induced PD-L1/CD274 at recycling endosomes, where it protects PD-L1/CD274 from being targeted for lysosomal degradation, likely by preventing its STUB1-mediated ubiquitination. May stabilize PD-L1/CD274 expression on antigen presenting cells and potentiates inhibitory signaling by PDCD1/CD279, its receptor on T-cells, ultimately triggering T-cell anergy.. | |
| Protein Sequence | MENGAVYSPTTEEDPGPARGPRSGLAAYFFMGRLPLLRRVLKGLQLLLSLLAFICEEVVSQCTLCGGLYFFEFVSCSAFLLSLLILIVYCTPFYERVDTTKVKSSDFYITLGTGCVFLLASIIFVSTHDRTSAEIAAIVFGFIASFMFLLDFITMLYEKRQESQLRKPENTTRAEALTEPLNA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MENGAVYS -------CCCCCCCC | 9.00 | 20068231 | |
| 7 | Phosphorylation | -MENGAVYSPTTEED -CCCCCCCCCCCCCC | 14.38 | 25106551 | |
| 8 | Phosphorylation | MENGAVYSPTTEEDP CCCCCCCCCCCCCCC | 14.79 | 28348404 | |
| 10 | Phosphorylation | NGAVYSPTTEEDPGP CCCCCCCCCCCCCCC | 40.68 | 28450419 | |
| 11 | Phosphorylation | GAVYSPTTEEDPGPA CCCCCCCCCCCCCCC | 40.54 | 28450419 | |
| 23 | Phosphorylation | GPARGPRSGLAAYFF CCCCCCCCHHHHHHH | 41.09 | 22210691 | |
| 28 | Phosphorylation | PRSGLAAYFFMGRLP CCCHHHHHHHHCCHH | 7.55 | 22210691 | |
| 167 | Ubiquitination | RQESQLRKPENTTRA HHHHHHCCCCCCCHH | 66.33 | 22053931 | |
| 171 | Phosphorylation | QLRKPENTTRAEALT HHCCCCCCCHHHHHC | 18.92 | 26434776 | |
| 178 | Phosphorylation | TTRAEALTEPLNA-- CCHHHHHCCCCCC-- | 42.47 | 29970186 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CKLF6_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CKLF6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CKLF6_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DUS10_HUMAN | DUSP10 | physical | 21900206 | |
| XRCC6_HUMAN | XRCC6 | physical | 21900206 | |
| SUMO2_HUMAN | SUMO2 | physical | 21900206 | |
| AT132_HUMAN | ATP13A2 | physical | 21900206 | |
| DNM3B_HUMAN | DNMT3B | physical | 21900206 | |
| CXCL7_HUMAN | PPBP | physical | 21900206 | |
| FAM9B_HUMAN | FAM9B | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |